Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 313 of 5804
-
Old drug, new trick: vancomycin may stop c. diff before it starts
Prevention Not yet recruitingThe purpose of this study is to evaluate the ability of oral vancomycin in preventing Clostridioides difficile infection (CDI) in patients that are simultaneously receiving antibiotics. Participants in this study will be placed randomly into two groups. The oral vancomycin treat…
Phase: PHASE2, PHASE3 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
AI-Powered 3D scanner could spot skin cancer before it spreads
Diagnosis Not yet recruitingThe background to this research is that frequent medical screening of the general population for melanoma is not feasible. The real challenge of this project is to develop an automatic process for detecting any potential melanoma. To this end, the project aims to design an algori…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
New TB tests for kids could save thousands of lives
Diagnosis Not yet recruitingStart4Kids: Evaluating the performance, feasibility, acceptability and cost effectiveness of computer-aided detection (CAD) of chest X-ray (CXR) and concurrent testing using novel diagnostics and non-sputum specimens for childhood tuberculosis (TB) in Bangladesh, Cameroon, Kenya …
Phase: NA • Sponsor: Liverpool School of Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:59 UTC
-
New hope for leukemia patients: experimental drug combo enters late-stage trial
Disease control Not yet recruitingThis study is an open, multicenter, dose-escalation and expansion, non-randomized phase II/III clinical trial to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of BL-M11D1 in combination with cytarabine + daunorubicin or venetoclax + …
Phase: PHASE2, PHASE3 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Radioactive 'Seeds' take on pancreatic cancer
Disease control Recruiting nowA unique approach for cancer treatment including radioactive sources named Alpha DaRT sources: Ra - 224 coated onto stainless steel tubes inserted into the tumor for the treatment of Locally Advanced Pancreatic Cancer .
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can a pulsatile drug schedule beat brain metastases in lung cancer?
Disease control Recruiting nowThe goal of this clinical trial is to clarify the efficacy and safety of the high-dose alternate-day furmonertinib in NSCLC with leptomeningeal metastasis. It will also explore the mechanism by which the high-dose alternate-day administration regimen enhances efficacy from a phar…
Phase: NA • Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New stroke drug combo aims to boost recovery in Late-Treated patients
Disease control Not yet recruitingThis is a multicenter, randomized, open-label, blinded-endpoint clinical trial designed to evaluate the efficacy and safety of early administration of eptifibatide following intravenous thrombolysis in patients with acute ischemic stroke who present 4.5 to 24 hours after symptom …
Phase: PHASE3 • Sponsor: Xinqiao Hospital of Chongqing • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New hope for kids with Hard-to-Treat ITP: daratumumab takes on rituximab
Disease control Recruiting nowThis randomized, open-label study aim to compare the efficacy and safety of Daratumumab (anti-CD38 monoclonal antibody) with Rituximab in pediatric ITP patients.This study will be conducted in pediatric ITP patients who had not responded to or had relapsed after previous glucocor…
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for mild stroke: catheter procedure could boost recovery
Disease control Not yet recruitingThis study assesses the efficacy and safety of endovascular treatment for acute mild basilar artery occlusion within a multicenter, prospective, open-label, endpoint-blinded, randomized controlled clinical trial.
Phase: NA • Sponsor: Feng Gao • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Timing is everything: new trial seeks to boost cancer treatment by scheduling immunotherapy just right
Disease control Not yet recruitingThis is a multicenter, open-label, randomized phase II clinical trial designed to evaluate the optimal timing of toripalimab administration during neoadjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Participants will receive gemcitabine and…
Phase: PHASE2 • Sponsor: Fujian Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Engineered immune cells take aim at multiple sclerosis and myasthenia gravis
Disease control Not yet recruitingThis is an open label, single-site, dose-escalation study in up to 15 participants with relapsed or refractory Neurological Autoimmune Diseases. This study aims to evaluate the safety and efficacy of the treatment with universal CD19/BCMA CAR T-cells(QT-019C).
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New antibody aims to keep myeloma at bay after transplant
Disease control Not yet recruitingThis is a prospective, single-arm clinical study designed to evaluate the efficacy and safety of the BCMA/CD3 bispecific antibody (CM336) as maintenance therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Menopause makeover: study tests if lifestyle changes can reverse aging and cut disease risk
Disease control Recruiting nowWhat if midlife women, who are inherently at an increased risk for future cardiometabolic disease due to transitioning into menopause, had access to a suite of evidence-based health interventions? Could these interventions reduce menopause-related inflammation, restore a healthie…
Phase: PHASE2, PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New stitch procedure could help obese patients shed pounds without surgery
Disease control Not yet recruitingEGO-Trial is the first multicenter study in France which aims to evaluate the efficacy of Endoscopic Sleeve Gastroplasty (ESG) in patients with obesity. This project fills a critical national gap by providing real-world, multicentric data from diverse French healthcare settings, …
Sponsor: IHU Strasbourg • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New cholesterol drug QLC7401 enters final testing phase
Disease control Not yet recruitingTo evaluate the efficacy, safety and immunogenicity of QCL7401 subcutaneous administration in patients with primary hypercholesterolemia or mixed hyperlipidemia with poorly controlled LDL-C elevated on optimized lipid-lowering therapy.
Phase: PHASE3 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New hope: interferon drug may stop deadly blood cancers from coming back after transplant
Disease control Not yet recruitingTo investigate the efficacy of interferon-α prophylaxis in patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) with TP53 mutation who were negative for minimal residual disease (MRD) by flow cytometry within 2 months after allogeneic hematopoietic stem c…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New bedside blood test could spot strokes in kids in minutes
Diagnosis Not yet recruitingThe goal of this study is to test the efficacy of a rapid bedside blood test in determining if a stroke is happening in children who present to the emergency department with stroke symptoms. The main questions it aims to answer are: * To determine the sensitivity of detecting a …
Sponsor: Boston Children's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Heated chemo during surgery: new hope for advanced pancreatic cancer?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and feasibility of a combined surgical and chemotherapy approach (pancreatectomy with cytoreductive surgery and HIPEC) in patients aged 18 and older with pancreatic ductal adenocarcinoma and synchronous peritoneal metastas…
Phase: NA • Sponsor: Unidade Local de Saúde São João • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could tailored tamoxifen doses keep more breast cancer patients on treatment?
Disease control Not yet recruitingIn Sweden, approximately 7000 women are diagnosed with hormone-sensitive breast cancer annually. According to international and national guidelines, most of these women are recommended anti-hormonal therapy for five to ten years to improve prognosis. Tamoxifen, one of the most wi…
Phase: PHASE3 • Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
AI-Powered smartwatch ECG could spot hidden heart failure at home
Diagnosis Recruiting nowThis prospective multicenter observational study will validate the accuracy of a previously developed artificial intelligence-enabled single-lead electrocardiogram (AI-ECG) model for identifying low ejection fraction and other structural heart disease phenotypes. Adult participan…
Sponsor: National Defense Medical Center, Taiwan • Aim: Diagnosis
Last updated Jun 27, 2026 12:00 UTC